Hipolin Ltd

As of June 30, 2026, Hipolin Ltd carries a market capitalization of 225.45M, placing it among publicly traded companies globally. Its enterprise value stands at 225.45M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Hipolin Ltd has 3.13M shares outstanding.

As of June 30, 2026, Hipolin Ltd trades at a trailing price-to-earnings ratio of 547.99.

As of June 30, 2026, Hipolin Ltd trades at an EV/EBITDA multiple of 898.22 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.40 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 225.45M versus a market cap of 225.45M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 6.99M in revenue per employee across its workforce of 23.00, a quick read on workforce productivity versus industry peers.

As of the close on October 22, 2026, Hipolin Ltd's stock has gained approximately 0.01% over the past 52 weeks. The 50-day moving average sits at 88.81, while the 200-day moving average is 74.68.

Over the twelve months ended June 30, 2026, Hipolin Ltd generated 160.80M in revenue and converted that into 392,000.00 in net income, yielding earnings per share of 0.13. EBITDA reached 251,000.00, while operating income came in at -1.28M.

Over the twelve months ended June 30, 2026, Hipolin Ltd posted a gross margin of 31.63, reflecting its pricing power and cost economics. The operating margin of -0.80 and net profit margin of 0.24 provide insight into operational efficiency.